ST
NVO

SAL Trading’s Novo Nordisk NVO Stock Holding History

SAL Trading’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-8,200
Closed -$746K – 32
2023
Q3 		$746K Buy
8,200
+600
+8% +$52.9K 1.05% 21
2023
Q2 		$615K Buy
7,600
+3,000
+65% +$245K 0.69% 26
2023
Q1 		$366K Sell
4,600
-10,000
-68% -$709K 0.19% 37
2022
Q4 		$988K Buy
+14,600
New +$856K 0.57% 20
2022
Q3 		– Sell
-12,000
Closed -$669K – 49
2022
Q2 		$669K Buy
+12,000
New +$666K 0.28% 28

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

SAL Trading's NVO Position: Q2 2022 in Review

SAL Trading sold out of Novo Nordisk (NVO) in Q2 2022, closing a stake of 107,800 shares — an estimated $5.98M sold.

SAL Trading first reported a position in NVO in Q4 2021 and held it in 2 quarters. The position peaked at $5.99M in Q1 2022. 934 funds tracked by Wall St. Rank hold NVO as of Q2 2022.

  • SAL Trading reported no remaining Novo Nordisk position as of Q2 2022 after selling out during the quarter.
  • SAL Trading sold 107,800 Novo Nordisk shares in Q2 2022, an estimated $5.98M.
  • SAL Trading first reported a position in Novo Nordisk in Q4 2021 and held it in 2 quarters.
  • SAL Trading's Novo Nordisk position peaked at $5.99M in Q1 2022.
  • 934 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2022.

Based on SAL Trading's 13F filing for Q2 2022, filed 15 Aug 2022.